Advanced search
Publication Cover
Arab Journal of Urology
An International Journal
Volume 19, 2021 - Issue 1: Urothelial carcinoma: New insights in diagnosis and treatment
Submit an article Journal homepage
1,076
Views
1
CrossRef citations to date
0
Altmetric
Management of NMIBC

The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status

Łukasz NowakDepartment of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, PolandORCID Iconhttps://orcid.org/0000-0003-4273-8196
ORCID Icon,
Wojciech KrajewskiDepartment of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, PolandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1727-2283
ORCID Icon,
Adrian PoterekDepartment of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, Poland
,
Anna ŚliwaDepartment of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, PolandORCID Iconhttps://orcid.org/0000-0002-8388-4379
ORCID Icon &
Romuald ZdrojowyDepartment of Urology and Urological Oncology, Wroclaw Medical University, Wroclaw, Poland
Pages 67-70 | Received 19 May 2020, Accepted 22 Jun 2020, Published online: 16 Jul 2020

References

  • Ślusarczyk A, Zapała P, Ł Z, et al. Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics. Int Urol Nephrol. 2019;51:1089–1099.
  • Babjuk M, Burger M, Compérat EM, et al. European association of urology guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ) - 2019 update. Eur Urol. 2019;76:639–657.
  • Yu J, Wang X, Teng F, et al. PD-L1 expression in human cancers and its association with clinical outcomes. Onco Targets Ther. 2016;9:5023–5039.
  • Powles T, Walker J, Williams JA, et al. The evolving role of PD-L1 testing in patients with metastatic urothelial carcinoma. Cancer Treat Rev. 2020;82:101925.
  • Moher D, Liberati A, Tetzlaff J, et al.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3:e123–e130.
  • Martínez R, Tapia G, De Muga S, et al. Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC. Oncoimmunology. 2019;8:1–8.
  • Delcourt C, Gemival P, Nouhaud FX, et al. Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC). World J Urol. 2020;38:1517–1524.
  • Kates M, Matoso A, Choi W, et al. Adaptive immune resistance to intravesical BCG in non-muscle invasive bladder cancer: implications for prospective BCG unresponsive trials. Clin Cancer Res. 2020;26:882–891.
  • Aydin AM, Baydar DE, Hazir B, et al. Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer treated with BCG immunotherapy. World J Urol. 2020. [Online ahead of print]. DOI:10.1007/s00345-019-03065-2.
  • Pierconti F, Raspollini MR, Martini M, et al. PD-L1 expression in bladder primary in situ urothelial carcinoma: evaluation in BCG-unresponsive patients and BCG responders. Virchows Arch. 2020. [Online ahead of print]. DOI:10.1007/s00428-020-02755-2.
  • Breyer J, Wirtz RM, Otto W, et al. High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients. Cancer Immunol Immunother. 2018;67:403–412.
  • Hussain SA, Birtle A, Crabb S, et al. From clinical trials to real-life clinical practice: the role of immunotherapy with PD-1/PD-L1 inhibitors in advanced urothelial carcinoma. Eur Urol Oncol. 2018;1:486–500.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.